Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7319 p466-467
2 October 2004

This article
Reprint   Photocopy

PDF 80K, Acrobat Reader

Letters

· Personal control
· Cholesterol testing
· Charitable donations
· Returned medicines
· Dispensing
· The profession
· The Society
· The Charter
· Retention fee


Letters to the Editor

Dispensing

Acceptable dispensing practice?

From Mr K. Sagar

My wife (a retired hospital pharmacist) showed me the letter from John Blake in the PJ of 11 September (p347). As a lay person I cannot comment on the accuracy of his concerns over dispensing practices. But you may be interested in the following experience I had recently.

My GP gave me a repeat prescription for “atorvastatin tablets 20mg, 56 tab”, which I gave to my local village pharmacy (a branch of a large national chain). I received from it a manufacturer’s cardboard box entitled “Sortis 20mg/100 Atorvastatin 20mg tablets” with the pharmacy’s own label correctly typed “56 atorvastatin tablets 20mg”. Inside was a patient information leaflet for “atorvastatin” 10 and 20mg tablets and a miscellaneous collection of foil packs as follows:

· Three packs of 10 Sortis 20mg tablets each embossed with the batch number and expiry date 12/2006 but with a label stuck on (presumably by the importer) giving the expiry date as 12/06
· One pack as above but with the importer’s label giving an expiry date of 12/03
· One pack as above but with only nine tablets
· One pack as above but with only four tablets
· One pack of only two tablets (no batch number or date)
· One pack of one tablet (no batch number or date)

My previous (identical) prescription was supplied by the same pharmacy in two “30 Lipitor 20mg tablets” boxes but contained similar “Sortis” tablets.

Although I am not worried that the wrong drug has been dispensed, and the date discrepancies may be due to the importer, is this good or acceptable dispensing? Others, less well informed than I am, might be confused by the differing brand names, labelling and external packaging. Having worked as a chemical engineer in the offshore oil industry for many years, I know that such inconsistencies, lack of precision and untidiness would not be acceptable there.

It would help if either GPs were to prescribe, or manufacturers to package their products, in consistent quantities thus avoiding part-pack dispensing.

Ken Sagar
Cuckfield, West Sussex

Send your letter to The Editor

Previous Topic (Returned medicines)
Next Topic (The profession)

Back to Top


©The Pharmaceutical Journal